相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Elevated tumour necrosis factor-alpha (TNF-α) biological activity in psoriatic skin lesions
P. ETTEHADI et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis
Alan Menter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Spontaneous remission of marginal zone B cell lymphoma in a patient with seropositive rheumatoid arthritis after discontinuation of infliximab-methotrexate treatment
R Thonhofer et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Recalcitrant, generalized pustular psoriasis:: rapid and lasting therapeutic response to antitumour necrosis factor-α antibody (infliximab)
K Schmick et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
Combining infliximab and methotrexate in fistulizing Crohn's disease resistant or intolerant to azathioprine
O Schröder et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study
AY Goedkoop et al.
ARTHRITIS RESEARCH & THERAPY (2004)
Treatment of recalcitrant pustular psoriasis with infliximab:: effective reduction of chemokine expression
S Benoit et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
Comment on methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis
PA Courtney et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2003)
Successful treatment with infliximab and methotrexate of pyostomatitis vegetans associated with Crohn's disease
G Bens et al.
BRITISH JOURNAL OF DERMATOLOGY (2003)
Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate
P Ostuni et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Addition of low-dose methotrexate to infliximab in the treatment of a patient with severe, recalcitrant pustular psoriasis
C Barland et al.
ARCHIVES OF DERMATOLOGY (2003)
Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease
F Baert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Disseminated tuberculosis, pulmonary aspergillosis and cutaneous herpes simplex infection in a patient with infliximab and methotrexate
JM van der Klooster et al.
INTENSIVE CARE MEDICINE (2003)
Methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis
N Kramer et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2002)
Infliximab for the treatment of severe pustular psoriasis
BE Elewski
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2002)
Rapid response to infliximab in severe pustular psoriasis, von Zumbusch type
MR Newland et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2002)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
SB Hanauer et al.
LANCET (2002)
Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial
U Chaudhari et al.
LANCET (2001)
Successful treatment of severe recalcitrant psoriasis with combination infliximab and methotrexate
B Kirby et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2001)
Pharmacokinetic considerations in the treatment of inflammatory bowel disease
M Schwab et al.
CLINICAL PHARMACOKINETICS (2001)
Infliximab and methotrexate in the treatment of rheumatoid arthritis
PE Lipsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
